Article
Development and implementation of site-specific Hepatitis C Virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study, a prospective single-arm intervention trial
2023-02-15
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Hepatitis C virus (HCV) is the leading indication for liver transplantation and liver-related mortality. The development of direct acting antivirals (DAA) and a simplified treatment algorithm with a >97% cure rate should make global elimination of HCV an achievable goal. Yet, vulnerable populations with high rates of HCV still have limited access to treatment. B...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 92b9aa2c-658d-510a-9a06-c787c8a3213c
- DOI
- 10.21203/rs.3.rs-2399039/v1
